Metabolic syndrome, originally described in 1988 as “syndrome X” by Reaven et al.(1), has
evolved in our collective thinking from a vague association of common chronic disease …

Abdominal obesity is a risk factor for cardiovascular disease worldwide, and it is becoming a
dramatic issue for national health systems. Overweight and obesity are highly associated …

The existence of a significant percentage of treated hypertensive patients presenting a
diminished renal function has been recently described. Mild renal function abnormalities are …

The obesity epidemic has reached nephrology in the form of increasing numbers of patients
with chronic kidney disease (CKD) caused by obesity-related metabolic disorders, IgA …

Abstract The National Heart, Lung, and Blood Institute's National Cholesterol Education
Program 2001 Adult Treatment Panel III report defined the metabolic syndrome as having at …

Background. The present study has been undertaken to unravel the critical factors involved
in the progression of diabetic nephropathy (DN). Methods. A unique type 2 diabetic rat …

The metabolic syndrome is defined by a constellation of risk factors, including abdominal
obesity, impaired glucose tolerance in association with hyperinsulinaemia and insulin …

抵抗(IR), CRP, 及血脂异常后, 高水平的血浆抵抗素与较低的eGFR 和较高的尿蛋白/肌酐有关,
提示高抵抗素是肾脏损害的危险因素. 抵抗素可能通过下述原因参与动脉粥样硬化(AS) …

Microalbuminuria has been shown to predict an increased probability of suffering a
cardiovascular event or death. It has also been shown to be decreased by antihypertensive …

OBJECTIVE: Metabolic abnormalities contribute to increases in the mortality rate of patients
on hemodialysis. Here, we estimate the importance and influence of metabolic syndrome …